CCRN Valuation

Cross Country Healthcare Inc

Add to Watchlist

Advanced Chart

13.590

+0.22(1.645%)1D

Overview
Forecast
Valuation
Earnings

CCRN Relative Valuation

CCRN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CCRN is overvalued; if below, it's undervalued.

Historical Valuation

Cross Country Healthcare Inc (CCRN) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.35 is considered Undervalued compared with the five-year average of 22.29. The fair price of Cross Country Healthcare Inc (CCRN) is between 20.92 to 27.04 according to relative valuation methord. Compared to the current price of 13.53 USD , Cross Country Healthcare Inc is Undervalued By 35.34%.

Relative Value

Fair Zone

20.92-27.04

Current Price：13.53

35.34%

Undervalued

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

1.05

P/B

Median3y

1.63

Median5y

2.07

25.41

FCF Yield

Median3y

22.86

Median5y

12.57

Competitors Valuation Multiple

The average P/S ratio for CCRN's competitors is 1.31, providing a benchmark for relative valuation. Cross Country Healthcare Inc Corp (CCRN) exhibits a P/S ratio of 0.37, which is -71.86% above the industry average. Given its robust revenue growth of -22.62%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

CCRN.O

Cross Country Healthcare Inc

0.37

Average P/S: 1.31

-22.62%